The Better Than Natural protocol is not a philosophy lecture. It is a daily execution framework combining exogenous androgens, selective androgen receptor modulators, growth hormone secretagogues, metabolic modulators, and cognitive enhancers to maintain supraphysiologic performance across strength, body composition, cognition, and longevity markers. This article documents a single 24-hour cycle of protocol implementation: what compounds enter the body, when, why, and what markers justify continuation or adjustment. You will see exact milligram doses, injection timing, oral administration windows relative to meals and training, and the blood panel schedule that determines whether this approach produces the intended receptor occupancy and tissue-specific effects without accumulating cardiovascular or metabolic debt.
Mechanism
The Better Than Natural protocol operates on androgen receptor agonism, growth hormone axis manipulation, glucose partitioning, and neurotransmitter modulation across multiple tissue types simultaneously. Testosterone enanthate at 150–200 mg weekly delivers stable serum androgen levels between 1200–1500 ng/dL, saturating androgen receptors in skeletal muscle while maintaining physiologic occupancy in cardiac and prostate tissue when estradiol conversion is controlled. Selective androgen receptor modulators like RAD-140 add tissue-selective anabolism at 10 mg daily, preferentially activating AR in muscle and bone with reduced prostate growth signaling due to differential coactivator recruitment.
Ipamorelin at 200 mcg three times daily stimulates growth hormone release through ghrelin receptor agonism without cortisol or prolactin elevation. This creates pulsatile GH secretion mimicking youthful patterns, driving IGF-1 synthesis in hepatic tissue and promoting lipolysis through hormone-sensitive lipase activation. Metformin at 500 mg twice daily activates AMP-activated protein kinase, improving insulin sensitivity through GLUT4 translocation and reducing hepatic gluconeogenesis. This combination keeps fasting glucose between 75–85 mg/dL and fasting insulin below 5 μIU/mL despite supraphysiologic androgen load.
Modafinil at 100 mg upon waking increases dopamine availability through dopamine transporter inhibition, extending wake-promoting effects for 10–12 hours without adenosine receptor antagonism that creates caffeine-style crashes. Nicotine patches delivering 7 mg over 24 hours provide steady cholinergic receptor activation, enhancing working memory and attentional control. The protocol synchronizes these mechanisms: anabolic signaling peaks during and after resistance training, GH pulses align with fasted periods and sleep onset, glucose partitioning favors nutrient storage in muscle glycogen over adipose triglyceride, and dopaminergic tone supports sustained cognitive output during work blocks.
Protocol
5:00 AM – Wake. Apply 7 mg nicotine patch to clean skin on upper arm. Oral administration of 100 mg modafinil, 500 mg metformin, 5 mg tadalafil. Tadalafil provides PDE5 inhibition for 36-hour half-life coverage, maintaining nitric oxide signaling and endothelial function. Subcutaneous injection of 200 mcg ipamorelin in abdominal fat. This first GH pulse occurs during the fasted state when growth hormone releasing hormone is naturally elevated.
6:30 AM – Fasted resistance training session. No pre-workout nutrition; glycogen depletion from overnight fast enhances AMPK activation and metabolic flexibility. Training focuses on compound movements: squat, bench press, deadlift variations with 75–85% of 1RM for 4–6 repetitions across 4–5 sets. Exogenous androgens allow maintenance of this training frequency and intensity year-round without overtraining symptoms.
8:00 AM – Post-training meal. 50 g whey isolate, 100 g white rice, 15 g MCT oil. Rapid-digesting protein and carbohydrate create insulin spike that drives amino acid uptake into muscle tissue sensitized by androgen receptor activation and mechanical tension. Second subcutaneous injection of 200 mcg ipamorelin. Oral administration of 10 mg RAD-140, 25 mg mk-677. The RAD-140 dosing window post-training capitalizes on elevated muscle protein synthesis signaling.
12:00 PM – Midday meal. 200 g chicken breast, 150 g sweet potato, 100 g broccoli, 20 g olive oil. Moderate protein and carbohydrate to sustain anabolism without insulin spikes that impair afternoon cognitive performance.
4:00 PM – Third subcutaneous injection of 200 mcg ipamorelin. Oral administration of 500 mg metformin. This timing precedes the evening meal by 2 hours, maximizing metformin’s glucose-lowering effect during dinner macronutrient intake.
6:00 PM – Evening meal. 250 g salmon, 200 g white rice, mixed green salad with 30 g avocado. Higher carbohydrate load in evening supports serotonin synthesis and sleep quality without concern for fat gain due to enhanced insulin sensitivity from metformin and increased metabolic rate from androgens.
Every Monday and Thursday, 8:00 PM – Intramuscular injection of 100 mg testosterone enanthate in ventrogluteal site using 25-gauge 1-inch needle. This twice-weekly frequency maintains stable serum levels with peak-trough variation of approximately 20%. Co-administered subcutaneously: 0.25 mg anastrozole to maintain estradiol between 25–35 pg/mL. Aromatase inhibition prevents estrogen-mediated water retention, gynecomastia, and potential negative feedback on hypothalamic-pituitary axis.
10:00 PM – Sleep preparation. Remove nicotine patch. Oral administration of 400 mg magnesium glycinate, 10 mg melatonin. Magnesium supports GABA receptor function and muscle relaxation. Melatonin synchronizes circadian rhythm and amplifies nocturnal growth hormone secretion. Target sleep duration: 7.5 hours, completing five 90-minute sleep cycles.
Monitoring
Blood panels occur every 6 weeks during protocol initiation, extending to every 12 weeks once stable dosing is established. Comprehensive metabolic panel tracks liver enzymes ALT and AST—elevation above 50 U/L signals hepatotoxicity requiring dose reduction or compound elimination. Creatinine and eGFR monitor renal function; creatinine above 1.3 mg/dL or eGFR below 60 mL/min/1.73m² indicates nephrotoxicity. Total testosterone, free testosterone, estradiol, SHBG, and LH/FSH establish androgenic status. Target ranges: total testosterone 1200–1500 ng/dL, free testosterone 300–400 pg/mL, estradiol 25–35 pg/mL, LH/FSH suppressed below 1 mIU/mL confirming hypothalamic suppression is complete.
Lipid panel assesses cardiovascular risk. Total cholesterol below 200 mg/dL, LDL-C below 100 mg/dL, HDL-C above 40 mg/dL, triglycerides below 100 mg/dL represent optimal ranges. Androgens typically reduce HDL-C by 20–30%; supplementation with 2 g daily omega-3 fatty acids and 500 mg niacin (flush-free form) mitigates this reduction. Apolipoprotein B below 80 mg/dL provides superior cardiovascular risk assessment compared to LDL-C alone. High-sensitivity C-reactive protein below 1.0 mg/L confirms absence of systemic inflammation.
Fasting glucose and fasting insulin quantify metabolic health. Despite supraphysiologic androgens impairing insulin sensitivity in some users, metformin intervention maintains fasting glucose between 75–85 mg/dL and fasting insulin below 5 μIU/mL. Hemoglobin A1c below 5.3% confirms excellent glycemic control over the preceding 90 days. IGF-1 between 250–350 ng/mL indicates effective growth hormone axis manipulation without reaching acromegalic ranges above 400 ng/mL. Prolactin should remain below 15 ng/mL; elevation suggests dopaminergic insufficiency or inappropriate GH secretagogue dosing.
Home monitoring includes daily morning body weight, weekly 7-site skinfold caliper measurements, and resting heart rate upon waking. Resting heart rate above 70 bpm suggests sympathetic overdrive from stimulants or inadequate recovery. Blood pressure checks every 3 days target values below 120/80 mmHg. Androgen-induced erythropoiesis can elevate hematocrit above 52%, increasing blood viscosity and cardiovascular risk—therapeutic phlebotomy of 500 mL every 8–12 weeks maintains hematocrit between 48–50%.
Risks and Mitigation
Suprahypothalamic GnRH suppression occurs within 2–3 weeks of initiating exogenous testosterone, reducing endogenous production to near-zero. Human chorionic gonadotropin at 500 IU subcutaneously twice weekly maintains testicular size and intratesticular testosterone, preserving fertility and reducing recovery time during protocol cessation. Post-cycle therapy using 20 mg tamoxifen daily for 6 weeks plus 25 mg enclomiphene every other day restores LH/FSH secretion, typically recovering baseline testosterone within 8–12 weeks.
Left ventricular hypertrophy develops with chronic androgen exposure above physiologic ranges. Echocardiography every 12 months quantifies interventricular septal thickness and posterior wall thickness—measurements above 12 mm suggest pathologic hypertrophy. Cardiovascular health on androgens requires managing blood pressure below 120/80 mmHg using 5 mg tadalafil daily for nitric oxide support and 5 mg nebivolol if additional beta-blockade is needed.
Hepatotoxicity risk is minimal with injectable testosterone and peptides but increases with 17-alpha-alkylated orals. RAD-140 at 10 mg daily rarely elevates liver enzymes, but monitoring remains essential. N-acetylcysteine at 600 mg twice daily provides glutathione precursor support. Elevation of ALT or AST above 2× upper limit of normal requires immediate cessation of the offending compound.
Androgenic alopecia accelerates in genetically susceptible individuals. Finasteride at 1 mg daily blocks 5-alpha-reductase, preventing testosterone conversion to dihydrotestosterone in scalp tissue. Topical minoxidil 5% twice daily to frontal and vertex scalp prolongs anagen phase. RU58841 at 50 mg in topical solution provides direct androgen receptor antagonism at the hair follicle without systemic anti-androgenic effects.
Comparisons
The Better Than Natural protocol differs fundamentally from testosterone replacement therapy (TRT) in dose, compound variety, and objective. TRT restores testosterone to physiologic range—typically 500–900 ng/dL total testosterone using 100–150 mg weekly testosterone cypionate or enanthate. The Better Than Natural protocol intentionally exceeds physiologic limits, targeting 1200–1500 ng/dL with additional tissue-selective modulators.
Standard TRT produces modest strength gains—approximately 5–10% increase in lean body mass over 12 months in hypogonadal men. The Better Than Natural protocol with stacked androgens, SARMs, and GH secretagogues generates 15–25% lean mass increases in the first year when combined with structured resistance training. Cognitive enhancement is negligible with TRT dose androgens but becomes pronounced with modafinil and nicotinic receptor activation.
Risk profiles diverge significantly. TRT at physiologic replacement doses minimally impacts cardiovascular markers when estradiol is managed—HDL-C reduction of 5–10%, no significant LVH in most users. The Better Than Natural protocol requires active mitigation: lipid support, blood pressure management, hematocrit control, and regular cardiac imaging. The trade-off is performance magnitude. TRT returns a hypogonadal individual to baseline function. Better Than Natural pushes past genetic potential in strength, recovery capacity, and work output.
Recovery and off-ramp considerations also differ. Discontinuing TRT in a hypogonadal patient returns them to deficiency, often necessitating lifelong treatment. Discontinuing Better Than Natural requires structured post-cycle therapy but typically restores endogenous production to pre-protocol levels within 3–6 months in individuals with previously normal baseline function. The protocol is cyclical by design; many users implement 16-week-on, 8-week-off patterns to manage health markers.
Common Mistakes
Inadequate estradiol management. Users frequently omit aromatase inhibitors or dose them reactively after gynecomastia symptoms appear. Estradiol should be measured at week 4 of initiating testosterone, with anastrozole titrated to maintain 25–35 pg/mL. Exemestane at 12.5 mg twice weekly represents an alternative for users experiencing joint pain from excessive estrogen suppression with anastrozole.
Ignoring insulin sensitivity. Supraphysiologic androgens impair glucose disposal in some individuals, particularly when combined with high-calorie surplus eating. Fasting glucose above 100 mg/dL or postprandial glucose exceeding 140 mg/dL indicate intervention is required. Metformin, berberine at 500 mg three times daily, or injectable GLP-1 agonists like semaglutide correct this before metabolic dysfunction becomes entrenched.
Excessive compound stacking. Adding trenbolone, nandrolone, or multiple SARMs simultaneously prevents identification of which compound produces specific effects or side effects. Start with testosterone alone for 8 weeks, establish stable blood markers, then add one compound at minimum effective dose. RAD-140 or mk-677 added individually for 6-week trials allows assessment of incremental benefit versus risk.
Neglecting cardiovascular monitoring. Users track gym performance and body composition obsessively while ignoring blood pressure, resting heart rate, and lipid panels. Sudden cardiac events in enhanced athletes typically occur in individuals with years of unmonitored hypertension and dyslipidemia. Blood pressure checks every 3 days and comprehensive panels every 6–12 weeks are non-negotiable.
Inadequate recovery between training sessions. Exogenous androgens increase work capacity but do not eliminate central nervous system fatigue or connective tissue stress. Training 6–7 days weekly with high volume and intensity produces overuse injuries—tendinopathy, joint pain, chronic fatigue. Four resistance sessions weekly with 48–72 hours between muscle group training optimizes growth without accumulating damage.
Bottom Line
- The Better Than Natural protocol is executed through precise timing of injectable testosterone 100 mg twice weekly, oral RAD-140 10 mg daily, subcutaneous ipamorelin 200 mcg three times daily, metformin 500 mg twice daily, and modafinil 100 mg upon waking.
- Blood panels every 6–12 weeks monitoring testosterone 1200–1500 ng/dL, estradiol 25–35 pg/mL, liver enzymes below 50 U/L, fasting glucose 75–85 mg/dL, and hematocrit below 52% determine protocol continuation or adjustment.
- Cardiovascular protection requires tadalafil 5 mg daily, blood pressure below 120/80 mmHg, lipid optimization with omega-3 and niacin, and annual echocardiography to detect left ventricular hypertrophy before it becomes irreversible.
- Fertility preservation uses hCG 500 IU twice weekly; hair protection uses finasteride 1 mg daily; estrogen control uses anastrozole 0.25 mg every other day titrated to bloodwork.
- This is not TRT. This is deliberate supraphysiologic enhancement with corresponding monitoring requirements and acceptance of reversible suppression of endogenous hormone production.